These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 19766110

  • 1. Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor.
    Aoyagi T, Kusakawa S, Sanbe A, Hiroyama M, Fujiwara Y, Yamauchi J, Tanoue A.
    Eur J Pharmacol; 2009 Nov 10; 622(1-3):32-6. PubMed ID: 19766110
    [Abstract] [Full Text] [Related]

  • 2. Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance.
    Nakamura K, Aoyagi T, Hiroyama M, Kusakawa S, Mizutani R, Sanbe A, Yamauchi J, Kamohara M, Momose K, Tanoue A.
    Eur J Pharmacol; 2009 Jun 24; 613(1-3):182-8. PubMed ID: 19375419
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I, Bruce MA, Leboulluec KL, Iben LG, Mattson GK, McGovern RT, Hogan JB, Leahy CL, Flowers SC, Stanley JA, Ortiz AA, Poindexter GS.
    Eur J Pharmacol; 2008 Aug 20; 590(1-3):224-32. PubMed ID: 18573246
    [Abstract] [Full Text] [Related]

  • 4. Enhanced glucose tolerance in the Brattleboro rat.
    Nakamura K, Yamashita T, Fujiki H, Aoyagi T, Yamauchi J, Mori T, Tanoue A.
    Biochem Biophys Res Commun; 2011 Feb 04; 405(1):64-7. PubMed ID: 21215256
    [Abstract] [Full Text] [Related]

  • 5. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A, Rägo L, Harro J.
    Br J Pharmacol; 1998 Aug 04; 124(7):1507-15. PubMed ID: 9723965
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S, Li DL, Simmons RM.
    J Pharmacol Exp Ther; 1999 May 04; 289(2):1031-40. PubMed ID: 10215684
    [Abstract] [Full Text] [Related]

  • 9. Vasopressin and angiotensin receptors of the medial septal area in the control of mean arterial pressure induced by vasopressin.
    Pavan de Arruda Camargo GM, Abrão Saad W, de Arruda Camargo LA.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep 04; 9(3):133-8. PubMed ID: 18957383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach.
    Oshikawa S, Tanoue A, Koshimizu TA, Kitagawa Y, Tsujimoto G.
    Mol Pharmacol; 2004 Mar 04; 65(3):623-9. PubMed ID: 14978240
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anorexia in rats caused by a valine-deficient diet is not ameliorated by systemic ghrelin treatment.
    Goto S, Nagao K, Bannai M, Takahashi M, Nakahara K, Kangawa K, Murakami N.
    Neuroscience; 2010 Mar 10; 166(1):333-40. PubMed ID: 20006681
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis.
    Mashiko S, Moriya R, Ishihara A, Gomori A, Matsushita H, Egashira S, Iwaasa H, Takahashi T, Haga Y, Fukami T, Kanatani A.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):113-7. PubMed ID: 19482021
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
    Kask A, Schiöth HB, Harro J, Wikberg JE, Rägo L.
    Can J Physiol Pharmacol; 2000 Feb 01; 78(2):143-9. PubMed ID: 10737677
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.